CHKP (CHKP) insider plans 4,744-share sale via Oppenheimer

Rhea-AI Filing Summary

An affiliated holder of CHKP has filed a notice of proposed sale of 4,744 ordinary shares, to be sold through Oppenheimer & Co. Inc. on the Nasdaq. The filing notes that 108,368,523 shares of this class are outstanding, providing context for the planned sale size.

The shares to be sold were originally acquired from the issuer through RSU and PSU grants between 2021 and 2024. The seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	4744	813501.12	108368523	02/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	05/03/2021	RSU	Issuer			2524	05/03/2021	N/A
Ordinary	05/11/2022	RSU	Issuer			1963	05/11/2022	N/A
Ordinary	05/11/2022	PSU	Issuer			943	05/11/2022	N/A
Ordinary	05/10/2023	RSU	Issuer			80	05/10/2023	N/A
Ordinary	02/15/2024	RSU	Issuer			1218	02/15/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CHKP Form 144 filing disclose about planned share sales?

The Form 144 filing discloses an intention to sell 4,744 ordinary shares of CHKP through Oppenheimer & Co. Inc. on Nasdaq. It is a notice of a potential sale by an affiliated holder, not confirmation that the transaction has already occurred.

How large is the planned CHKP share sale compared with shares outstanding?

The filing shows a planned sale of 4,744 ordinary shares versus 108,368,523 shares outstanding for this class. This indicates the proposed transaction is very small relative to the total share base disclosed in the document.

How were the CHKP shares in the Form 144 originally acquired?

The shares covered by the Form 144 were acquired from the issuer via restricted stock units (RSUs) and performance stock units (PSUs) granted between 2021 and 2024. These awards represent equity compensation rather than open‑market purchases.

Which broker and exchange are involved in the CHKP Form 144 sale?

The filing lists Oppenheimer & Co. Inc. at 85 Broad Street, New York, as the broker handling the proposed sale of 4,744 ordinary shares, with the securities to be traded on the Nasdaq exchange according to the disclosure.

What representations does the CHKP seller make in the Form 144 notice?

The seller represents that they do not know of any material adverse information about CHKP’s current or prospective operations that has not been publicly disclosed. This statement is required when filing a Form 144 notice for a proposed sale of restricted or control securities.